77 Ill. Adm. Code 698.40
Health Record – Recording and Reporting
Section 698
Section 698.40 Health Record
– Recording and Reporting
All health care providers which
administer pertussis vaccine shall maintain records of the administration of
pertussis vaccine and reactions to the vaccine in the following manner:
a)
Upon administering a pertussis vaccine to a child in this
State, a health care provider shall record and retain as part of the child's
permanent health record
the following information:
1)
The date the vaccine was administered,
2)
The manufacturer
of the vaccine administered,
3)
A lot number and any other available identifying
information of the vaccine that was administered, and
4)
The name
, address, telephone number,
and title of the
health care provider who administered the vaccine.
(Section 7 of the Act.)
b) Recording and Reporting Major Adverse Reactions.
If,
within 30 days of administering a pertussis vaccine the health care provider
has reason to believe that the recipient of the vaccine has had a major adverse
reaction, the health care provider shall
take the following action:
1)
Record all relevant information,
in the professional
judgment of the health care provider
, in the child's permanent medical
record, and
2)
Report the information, including the manufacturer and lot
number, to the Department.
(Section 8 (a) and (b) of the Act.) The
written report shall be on forms provided by the Department containing the
following information:
A) Name and address of the health care provider which administered
the pertussis vaccine.
B) The age, weight, and sex of the recipient of the vaccine.
C) A description of the major adverse reaction experienced by the
recipient of the vaccine and any other information the health care provider
determines is relevant.
D) The manufacturer and lot number of the vaccine administered.
c) Reporting forms are as follows:
1) Adverse Reaction Report (Drugs and Biologicals) FDA 1639 (786)
OMB No. 0910-0230, Department of Health and Human Services, Public Health
Services Board and Drug Administration (HFN-730) Rockville, MD 20857
2) Report of Adverse Event Following Immunization CDC 71.19 Rev.
9-85-OMB No. 0920-0039 (9/87), Department of Health and Human Services, Center
for Disease Control, Atlanta, GA 30333